NEUROSCIENCES MOSANES
ActiveSummary
NEUROSCIENCES MOSANES has been active since 1992 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €599,783 and a net result of €16,812. Equity remains stable across the filed financial years (±0.9% per year). The computed 12-month bankruptcy probability is below 0.1% (very low).
Articles of association
What the company does
- DurationHow long the company exists; usually unlimited, so until it is dissolved.
- Unlimited
- Name clauseThe name the company operates under according to its articles.
- NEUROSCIENCES MOSANES
- Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
- “Région wallonne, tout transfert porté à connaissance Conseil provincial compétent Ordre des Médecins” (deed in French)
Who represents it, and how
- Board ruleHow the board is made up, meets and takes decisions.
- “Avec ou sans limitation durée, organe d'administration” (deed in French)
Capital, shares and profit
- Kind of sharesWhich classes of shares exist and what rights each class carries.
- “Nominatives, registre des actions nominatives” (deed in French)
- Transfer restrictionWhether shareholders may sell their shares freely or need approval first.
- “Moitié cédant moitié acquéreurs au prorata actions acquises, prix notification initiale ou expertise en contestation” (deed in French)
- Share issue ruleHow and by whom new shares can be issued.
- One provision in the deed
Oversight and winding up
- Dissolution ruleWhen and by whom the company can be dissolved.
- “Prévues pour les modifications aux statuts, assemblée générale” (deed in French)
- Liquidation ruleHow assets are shared after dissolution: creditors first, then shareholders.
- “Pour quelque cause et à quelque moment que ce soit, questions vie privée des patients et/ou secret professionnel des actionnaires” (deed in French)